Brookfield Corp’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-51,911
Closed -$3.77M 206
2023
Q2
$3.77M Sell
51,911
-4,366
-8% -$295K 0.01% 319
2023
Q1
$4.05M Buy
56,277
+50,875
+942% +$3.89M 0.02% 330
2022
Q4
$403K Sell
5,402
-17,446
-76% -$1.25M ﹤0.01% 548
2022
Q3
$1.5M Buy
+22,848
New +$1.75M 0.01% 502
2020
Q4
Sell
-3,923
Closed -$340K 454
2020
Q3
$340K Sell
3,923
-10,306
-72% -$858K ﹤0.01% 361
2020
Q2
$1.15M Buy
+14,229
New +$1.13M 0.01% 272
2013
Q3
Sell
-7,700
Closed -$570K 178
2013
Q2
$570K Buy
+7,700
New +$516K ﹤0.01% 165

Other funds holding CRI

Brookfield Corp's CRI Position: Q3 2023 in Review

Brookfield Corp sold out of Carter's (CRI) in Q3 2023, closing a stake of 51,911 shares — an estimated $3.77M sold.

Brookfield Corp first reported a position in CRI in Q2 2013 and held it in 7 quarters. The position peaked at $4.05M in Q1 2023. 301 funds tracked by Wall St. Rank hold CRI as of Q3 2023.

  • Brookfield Corp reported no remaining Carter's position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 51,911 Carter's shares in Q3 2023, an estimated $3.77M.
  • Brookfield Corp first reported a position in Carter's in Q2 2013 and held it in 7 quarters.
  • Brookfield Corp's Carter's position peaked at $4.05M in Q1 2023.
  • 301 funds tracked by Wall St. Rank held Carter's as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.